(Q35700596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Emilio Fernandez-Espejo

series ordinal

1

1 reference

9 August 2017

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

15-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1385/mn:29:1:15

26 December 2019

exact match

0 references

cites work

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

1 reference

12 December 2020

Neuroprotective effect of riluzole in MPTP-treated mice

1 reference

12 December 2020

Identification and characterization of postsynaptic D1- and D2-dopamine receptors in the cardiovascular system

1 reference

12 December 2020

Parkinson's disease and exposure to rural environmental factors: a population based case-control study

1 reference

12 December 2020

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

1 reference

12 December 2020

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.

1 reference

12 December 2020

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

12 December 2020

Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.

1 reference

12 December 2020

Growth factors in chromaffin cells

1 reference

12 December 2020

Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-beta

1 reference

12 December 2020

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

12 December 2020

Involvement of molecular chaperones in intracellular protein breakdown

1 reference

12 December 2020

GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.

1 reference

12 December 2020

D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding

1 reference

12 December 2020

Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion.

1 reference

12 December 2020

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

12 December 2020

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

12 December 2020

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

12 December 2020

Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.

1 reference

12 December 2020

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

1 reference

12 December 2020

Pre- and postnatal development of rat retroperitoneal paraganglia

1 reference

12 December 2020

Selegiline use to prevent progression of Parkinson's disease. Experience in 22 de novo patients

1 reference

12 December 2020

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

1 reference

12 December 2020

Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

1 reference

12 December 2020

Neuroprotective and neurorestorative properties of GDNF.

1 reference

12 December 2020

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

12 December 2020

Dopamine cell replacement: Parkinson's disease

1 reference

12 December 2020

Proteasomal function is impaired in substantia nigra in Parkinson's disease

1 reference

12 December 2020

Creatine and cyclocreatine attenuate MPTP neurotoxicity.

1 reference

12 December 2020

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

12 December 2020

Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease

1 reference

12 December 2020

Dopamine D2 receptor gene expression and binding sites in adrenal medulla and pheochromocytoma

1 reference

12 December 2020

Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease

1 reference

12 December 2020

Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism.

1 reference

12 December 2020

Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen.

1 reference

12 December 2020

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

1 reference

12 December 2020

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

1 reference

12 December 2020

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

12 December 2020

In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease

1 reference

12 December 2020

Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence

1 reference

12 December 2020

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group

1 reference

12 December 2020

United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.

1 reference

12 December 2020

Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay.

1 reference

12 December 2020

Changes in cytokines and neurotrophins in Parkinson's disease

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons.

1 reference

12 December 2020

Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.

1 reference

12 December 2020

Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line

1 reference

12 December 2020

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

1 reference

12 December 2020

Iron histochemistry of the substantia nigra in Parkinson's disease

1 reference

12 December 2020

Neural transplantation as a therapy for Parkinson's disease

1 reference

12 December 2020

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

12 December 2020

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

12 December 2020

Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum.

1 reference

12 December 2020

Expression of phenylethanolamine N-methyltransferase in rat sympathetic ganglia and extra-adrenal chromaffin tissue

1 reference

12 December 2020

Understanding cell death in Parkinson's disease.

1 reference

12 December 2020

Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour

1 reference

12 December 2020

Neuroprotection in Parkinson's disease: clinical trials

1 reference

12 December 2020

Is neural cell transplantation ready for the clinic?

1 reference

12 December 2020

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

1 reference

12 December 2020

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

12 December 2020

A rationale for dopamine agonists as primary therapy for Parkinson's disease

1 reference

12 December 2020

Parkinson's disease. A genetic study

1 reference

12 December 2020

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

12 December 2020

Improving the survival of grafted dopaminergic neurons: a review over current approaches.

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

1 reference

12 December 2020

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

1 reference

12 December 2020

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

1 reference

12 December 2020

Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion

1 reference

12 December 2020

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

12 December 2020

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

1 reference

12 December 2020

Bovine chromaffin cells release a transforming growth factor-beta-like molecule contained within chromaffin granules

1 reference

12 December 2020

Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing

1 reference

12 December 2020

Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

1 reference

12 December 2020

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

1 reference

12 December 2020

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

12 December 2020

Therapeutic potential of nerve growth factors in Parkinson's disease

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo.

1 reference

12 December 2020

Neural transplantation: a hope for patients with Parkinson's disease

1 reference

12 December 2020

The trophic cocktail made by adrenal chromaffin cells

1 reference

12 December 2020

Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.

1 reference

12 December 2020

Recent advances in the genetics and pathogenesis of Parkinson disease

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

1 reference

12 December 2020

Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats.

1 reference

12 December 2020

Identifiers

DOI

10.1385/MN:29:1:15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034220%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 December 2019

0 references

1 reference